FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382751308> ?p ?o ?g. }

• W4382751308 abstract "Background Myocardial ischemia is caused by epicardial coronary artery stenosis or atherosclerotic disease affecting microcirculation. Trimetazidine (TMZ), promotes glucose oxidation which optimizes cellular energy processes in ischemic conditions. Small studies demonstrated protective effects of TMZ in terms of reducing myocardial injury after percutaneous coronary intervention (PCI), its effect on microcirculation using contemporary investigative methods has not been studied. The aim of the study was to examine effects of trimetazidine, given before elective PCI, on microcirculation using invasively measured index of microcirculatory resistance (IMR). Methods This was prospective, single blinded, randomized study performed in a single university hospital. It included consecutive patients with an indication for PCI of a single, de novo , native coronary artery lesion. Patients were randomly assigned to receive either TMZ plus standard therapy (TMZ group) or just standard therapy. Coronary physiology indices fractional flow reserve (FFR), coronary flow reserve (CFR) and index of microcirculatory resistance (IMR) were measured before and after PCI using coronary pressure wire. Results We randomized 71 patients with similar clinical characteristics and risk profile, previous medications and coronary angiograms. Patientshad similar values of Pd/Pa, FFR and CFR prior to PCI procedure. After PCI, FFR values were higher in TMZ group, while IMR values were lower in this group respectively (FFR TMZ + 0.89 ± 0.05 vs. TMZ – 0.85 ± 0.06, p = 0.007; CFR TMZ + 2.1 ± 0.8 vs. TMZ- 2.3 ± 1.3, p = 0.469; IMR TMZ + 18 ± 9 vs. TMZ- 24 ± 12, p = 0.028). In two-way repeated measures ANOVA PCI was associated with change in FFR values (TMZ p = 0.050; PCI p &lt; 0.001; p for interaction 0.577) and TMZ with change in IMR values (TMZ p = 0.034, PCI p = 0.129, p for interaction 0.344). Conclusion Adding trimetazidine on top of medical treatment prior to elective PCI reduces microvascular dysfunction by lowering postprocedural IMR values when compared to standard therapy alone." @default.
• W4382751308 created "2023-07-01" @default.
• W4382751308 creator A5003391790 @default.
• W4382751308 creator A5004355431 @default.
• W4382751308 creator A5008044162 @default.
• W4382751308 creator A5008458970 @default.
• W4382751308 creator A5020770082 @default.
• W4382751308 creator A5042346173 @default.
• W4382751308 creator A5068669038 @default.
• W4382751308 creator A5078591149 @default.
• W4382751308 creator A5081261276 @default.
• W4382751308 date "2023-06-30" @default.
• W4382751308 modified "2023-09-26" @default.
• W4382751308 title "The imPAct of Trimetazidine on MicrOcirculation after Stenting for stable coronary artery disease (PATMOS study)" @default.
• W4382751308 cites W1518475843 @default.
• W4382751308 cites W1560711408 @default.
• W4382751308 cites W1979691471 @default.
• W4382751308 cites W2004389112 @default.
• W4382751308 cites W2008437352 @default.
• W4382751308 cites W2032915282 @default.
• W4382751308 cites W2046991068 @default.
• W4382751308 cites W2066907392 @default.
• W4382751308 cites W2084103429 @default.
• W4382751308 cites W2157478912 @default.
• W4382751308 cites W2317683134 @default.
• W4382751308 cites W2402590753 @default.
• W4382751308 cites W2461693780 @default.
• W4382751308 cites W2761080014 @default.
• W4382751308 cites W2907234550 @default.
• W4382751308 cites W2912125699 @default.
• W4382751308 cites W2946105763 @default.
• W4382751308 cites W2971736008 @default.
• W4382751308 cites W2997590959 @default.
• W4382751308 cites W3011371150 @default.
• W4382751308 cites W3014622906 @default.
• W4382751308 cites W3017579290 @default.
• W4382751308 cites W3039582598 @default.
• W4382751308 cites W3081960618 @default.
• W4382751308 cites W3124073716 @default.
• W4382751308 cites W3133907569 @default.
• W4382751308 cites W3204001571 @default.
• W4382751308 cites W3215657276 @default.
• W4382751308 cites W4281840112 @default.
• W4382751308 cites W4285592798 @default.
• W4382751308 cites W4296691249 @default.
• W4382751308 cites W45135017 @default.
• W4382751308 doi "https://doi.org/10.3389/fcvm.2023.1112198" @default.
• W4382751308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37456821" @default.
• W4382751308 hasPublicationYear "2023" @default.
• W4382751308 type Work @default.
• W4382751308 citedByCount "0" @default.
• W4382751308 crossrefType "journal-article" @default.
• W4382751308 hasAuthorship W4382751308A5003391790 @default.
• W4382751308 hasAuthorship W4382751308A5004355431 @default.
• W4382751308 hasAuthorship W4382751308A5008044162 @default.
• W4382751308 hasAuthorship W4382751308A5008458970 @default.
• W4382751308 hasAuthorship W4382751308A5020770082 @default.
• W4382751308 hasAuthorship W4382751308A5042346173 @default.
• W4382751308 hasAuthorship W4382751308A5068669038 @default.
• W4382751308 hasAuthorship W4382751308A5078591149 @default.
• W4382751308 hasAuthorship W4382751308A5081261276 @default.
• W4382751308 hasBestOaLocation W43827513081 @default.
• W4382751308 hasConcept C126322002 @default.
• W4382751308 hasConcept C12722491 @default.
• W4382751308 hasConcept C164705383 @default.
• W4382751308 hasConcept C2777927741 @default.
• W4382751308 hasConcept C2777987666 @default.
• W4382751308 hasConcept C2778213512 @default.
• W4382751308 hasConcept C2778707443 @default.
• W4382751308 hasConcept C2780400711 @default.
• W4382751308 hasConcept C3019004856 @default.
• W4382751308 hasConcept C45393284 @default.
• W4382751308 hasConcept C500558357 @default.
• W4382751308 hasConcept C71924100 @default.
• W4382751308 hasConceptScore W4382751308C126322002 @default.
• W4382751308 hasConceptScore W4382751308C12722491 @default.
• W4382751308 hasConceptScore W4382751308C164705383 @default.
• W4382751308 hasConceptScore W4382751308C2777927741 @default.
• W4382751308 hasConceptScore W4382751308C2777987666 @default.
• W4382751308 hasConceptScore W4382751308C2778213512 @default.
• W4382751308 hasConceptScore W4382751308C2778707443 @default.
• W4382751308 hasConceptScore W4382751308C2780400711 @default.
• W4382751308 hasConceptScore W4382751308C3019004856 @default.
• W4382751308 hasConceptScore W4382751308C45393284 @default.
• W4382751308 hasConceptScore W4382751308C500558357 @default.
• W4382751308 hasConceptScore W4382751308C71924100 @default.
• W4382751308 hasLocation W43827513081 @default.
• W4382751308 hasLocation W43827513082 @default.
• W4382751308 hasLocation W43827513083 @default.
• W4382751308 hasOpenAccess W4382751308 @default.
• W4382751308 hasPrimaryLocation W43827513081 @default.
• W4382751308 hasRelatedWork W1493283488 @default.
• W4382751308 hasRelatedWork W2145553842 @default.
• W4382751308 hasRelatedWork W2324515210 @default.
• W4382751308 hasRelatedWork W2740527910 @default.
• W4382751308 hasRelatedWork W2790962264 @default.
• W4382751308 hasRelatedWork W2890914369 @default.
• W4382751308 hasRelatedWork W2943877442 @default.
• W4382751308 hasRelatedWork W2948516153 @default.
• W4382751308 hasRelatedWork W3039067337 @default.

• next